Xtant Medical Holdings (XTNT)

• Market cap: $44.9M
• 1 day: -2.44%
• 5 days: -18.05%
• 1 month: -3.47%
• 3 months: -28.75%
• 6 months: -49.2%
• Year to date: -57.16%
• 1 year: -50.77%
• 5 years: -72.88%
• 10 years: -97.87%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Employees: 151